Marchi S, Bittremieux M, Missiroli S, Morganti C, Patergnani S, Sbano L, et al
Unlike many single-target agents, SFNs ability to simultaneously engage multiple vulnerability nodes in cancer cells reduces the likelihood of resistance development and enhances its therapeutic potential
doi: 10.1007/s00467-022-05739-3 4 Kidney Disease: Improving Global Outcomes (KDIGO)
Our products are for external use only, unless otherwise indicated
Precautions of Lycopene with L-Arginine And L-Carnitine Tablets Use this product at recommended dose
You may not be suitable if pregnant, breastfeeding or managing certain medical conditions